Global Blood Therapeutics (GBT) Reports In-Line Q3 Loss

November 9, 2016 4:12 PM EST
Get Alerts GBT Hot Sheet
Trade GBT Now!
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Global Blood Therapeutics (NASDAQ: GBT) reported Q3 EPS of ($0.58), in-line with the analyst estimate of ($0.58).

Cash and cash equivalents totaled $217.8 million at September 30, 2016, compared with $148.5 million at December 31, 2015.

For earnings history and earnings-related data on Global Blood Therapeutics (GBT) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment